Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - FREE CASH FLOW
Free Cash Flow TRVI - Trevi Therapeutics, Inc.
-31.8 M
LAST VALUE
-4.89%
2 YEAR CAGR
-11.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR